价格

BERLIN-CHEMIE AG

ACTIVE

147 Tsarigradsko Shose, Sofia, Stolichna, 保加利亚www.berlin-chemie.deSubsidiary

概览

试验阶段分布

阶段

试验数

占比

1 期

22.2%

4 期

11.1%

试验状态分布

进行中（未招募）

77.8%

已完成

22.2%

相关临床试验

该机构主办的试验（9）

A comparative bioavailability of reformulated ibuprofen 2% and 4% oral suspensions (Berlin Chemie AG) and reference ibuprofen (Nurofen®) 200 mg/5 ml oral suspension in healthy male and female adult subjects under fasting conditions: an open-label, randomized, single-dose, three-period, three-treatment, three-sequence crossover study

A prospective non-interventional study to assess quality of life and COPDsymptoms in patients with COPD on LAMA/LABA/ICS triple therapy withElebrato® Ellipta®

已完成

observational

May 2023931 名受试者

The purpose of this study is to investigate the efficacy and safety of the ibuprofen suspension, developed by Berlin-Chemie AG for oral administration (20 mg/ml and 40 mg/ml) compared to Nurofen® in reducing fever and pain in children at the age of 3-9 years old with uncomplicated acute otitis media.

进行中（未招募）

Dec 2015135 名受试者

Effects of nebivolol on the cardiovascular functions, thermoregulation and blood flow during real and simulated conditions of microgravity - MISSION Medicine In Space Study - Investigation Of Nebivolol

1 期

进行中（未招募）

Jan 2008

EBIVOLOL OR METOPROLOL IN ARTERIAL OCCLUSIVE DISEASEA DOUBLE-BLIND, RANDOMISED CLINICALDeutscher Titel: Nebivolol im Vergleich zu Metoprolol bei peripherer arterieller VerschlusskrankheitEine randomisierte, doppel-blinde klinische Studie - NORMA

进行中（未招募）

Oct 2006160 名受试者

Effects of Frovatriptan as Prophylactic Treatment of Cluster Headache, a Multi-Center, Placebo Controlled, Randomized, Double-Blind Prospective Phase III Parallel-Group Trial Comparing Frovatriptan with Placebo

进行中（未招募）

Aug 200680 名受试者

RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE IV TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A GASTRO-RESISTANT FILM-COATED PANCREATIN TABLET FOR LIPID DIGESTION AND ABSORPTION IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY DUE TO CHRONIC PANCREATITIS BY MEANS OF13C-MIXED TRIGLYCERIDE BREATH TEST - CPI 002

进行中（未招募）

Sep 200520 名受试者

RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE IV TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AN ENTERIC-COATED PANCREATIN TABLET FOR LIPID DIGESTION AND ABSORPTION IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY DUE TO CHRONIC PANCREATITIS BY MEANS OF 13C-MIXED TRIGLYCERIDE BREATH TEST - CPI 003

进行中（未招募）

May 200520 名受试者

第 1 页，共 2 页

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

EMA

European Medicines Agency

药物批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

Bilaxten 2.5 mg/ml Oral Solution

NPRA

2025-12-25

Bilaxten 2.5 mg/ml Oral Solution

DEBROMU 40MG F.C.TABLET

SFDA

2025-07-18

Levothyroxine Sodium Tablets

NMPA

2024-12-13

Levothyroxine Sodium Tablets

Dapoxetine Hydrochloride Tablet

NMPA

2024-05-31

资讯

暂无资讯文章

返回机构列表